Cigna Stops Breaking Out Covid Impact With Virus Here to Stay
(Bloomberg) -- Cigna Corp. will stop breaking out the impact of Covid-19 on its financial results as the disruption from the virus becomes just a part of the normal course of business.
“As time progresses, Covid-related impacts and the ongoing performance of the business are becoming more intertwined,” Chief Executive Officer David Cordani said on a call Thursday with analysts after the health-insurance giant reported third-quarter results that beat Wall Street estimates. “We no longer believe it's instructive to continue to quantify the impact of Covid-19.”
The question of whether to delineate Covid's effects has important implications for investors, particularly for health-care companies. Breaking out a number can give more visibility into how a business is exposed to swells and ebbs of the virus. But as the distance from Covid's initial shock increases, and the pandemic becomes endemic, trying to separate Covid from everything else will get harder.
One of Cigna's rivals is moving in the other direction. Humana Inc., which cut its profit forecast for the year Wednesday on higher-than-expected virus-related costs, said it would include a specific provision for Covid headwinds when it releases detailed financial projections for 2022.
In its second-quarter earnings report in August, Cigna estimated that Covid would shave its profit in 2021 by $2.50 a share, double the impact it had told investors to expect earlier. The results sent shares plunging at the time. Cigna now expects 2021 adjusted earnings of at least $20.35 per share.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.